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Mast cells are tissue-resident immune cells that play
a central role in allergic disease. These contributions
are largely dependent on the acquisition of antigen-
specific immunoglobulin E (IgE). Despite this require-
ment, studies of mast cell and IgE interactions have
overlooked the mechanism by which mast cells
acquire IgE from the blood. To address this gap, we
developed reporter IgE molecules and employed
imaging techniques to study mast cell function
in situ. Our data demonstrate that skin mast cells
exhibit selective uptake of IgE based on perivascular
positioning. Furthermore, perivascular mast cells
acquire IgE by extending cell processes across the
vessel wall to capture luminal IgE. These data
demonstrate how tissue mast cells acquire IgE
and reveal a strategy by which extravascular cells
monitor blood contents to capture molecules central
to cellular function.
INTRODUCTION
Mast cells are hematopoietic, tissue-resident cells that have
been considered to play diverse roles in host defense and
immune regulation as well as a central role in allergic disease
(Galli and Tsai, 2010; Gould and Sutton, 2008; Locksley, 2010).
Despite these many potential roles, recent studies, by using
mouse strains with targeted mast cell deletion, have primarily
served to underscore the mast cell contribution to the clinical
manifestations of allergic disease (Dudeck et al., 2011; Feyera-
bend et al., 2011).
The mast cell contribution to allergy is largely dependent on
the acquisition of monomeric immunoglobulin E (IgE) on the
surface of mast cells through expression of the high affinity IgE
receptor (FcεRI) (Kraft and Kinet, 2007). Though FcεRI can be
detected on the surface of mast cell precursors (Hallgren and
Gurish, 2007), expression of FcεRI on tissue-resident mast cells
increases proportionally with serum IgE titers, suggesting the
tissue as a primary site of IgE acquisition (Kraft and Kinet,166 Immunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc.2007; Yamaguchi et al., 1997). Once mast cells are loaded with
IgE, subsequent antigen binding leads to crosslinking of FcεRI
molecules and the immediate release of preformed mediators,
such as histamine, as well as synthesis of lipid and protein medi-
ators (Galli and Tsai, 2010).
Studies of the mast cell-IgE axis have focused on the regula-
tion of IgE production as well as the clinical manifestations
of hypersensitivity responses following antigen exposure. Few
studies have examined how mast cells acquire unbound IgE.
Defining the mechanism by which mast cells capture IgE will
fill a gap in our understanding of the mast cell-IgE axis and
may provide new therapeutic approaches to severe allergic
disorders.
Although cell-bound IgE is found primarily in tissues, IgE
production by plasma cells occurs mostly in the bone marrow,
spleen, and lymph nodes (Luger et al., 2009; McMenamin
et al., 1992; Talay et al., 2012; Yang et al., 2012). Thus, the local-
ization of IgE production is anatomically distinct from sites of IgE
acquisition and effector function. As the amount of surface-
bound IgE by tissue mast cells directly reflects the size of the
serum IgE pool (Kraft and Kinet, 2007), the vasculature acts as
a conduit by which unbound IgE is distributed to tissue mast
cells. The vasculature also acts as a potential barrier to IgE
uptake and could thereby regulate IgE delivery to tissue sites.
Mast cells show a preference toward perivascular localization
within tissue, wherein a majority of mast cells lie in close prox-
imity to the basal side of the vessel wall (Galli and Tsai, 2010).
We hypothesized that this preferential localization might position
mast cells to acquire IgE by a mechanism that requires cells to
surmount the endothelial barrier. By using reporter IgE mole-
cules, in vivo imaging techniques, and mast cell reporter mice,
we demonstrate that perivascular mast cells dynamically extend
processes into the vascular compartment to selectively acquire
IgE from the blood.
RESULTS
Heterogeneous IgE Uptake by Skin Mast Cells
Passive diffusion of blood-borne IgE across the vasculature has
been considered to be the primary means by which tissue mast
cells acquire IgE. However, we hypothesized a more active
mechanism of IgE acquisition by mast cells, which would lead
to selective uptake of IgE by a subset of mast cells. Supporting
Figure 1. Heterogeneous Uptake of IgE
from Blood by Skin Mast Cells
(A) Skin (left panel) and peritoneal (right panel)
mast cells from 4get BALB/cmice were stained for
IgE. Gray histograms represent IgE staining on
mast cells from IgE-deficient 4getxRag2/
controls. Lines within histograms represent the
percent of cells within the indicated gate.
(B) Peritoneal (top row) and ear skin mast cells
(bottom row) from 4getxRag2/ mice were
examined at the indicated times following a 10 mg
i.v. infusion of monoclonal IgE. Histograms depict
mast cell surface IgE. Shaded histograms repre-
sent control mice. The percent of IgE+ cells in the
gated area of the histogram is also depicted.
These data are representative of three indepen-
dent experiments with two to three mice at each
time point.
(C) Ear skin (left) and peritoneal (right) mast cells
from 4getxRag2/ were stained with anti-FcεRI
antibody. Gray histograms represent the isotype
control. Results are representative of three mice
for each plot.
See also Figure S1.
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in which mast cells constitutively express enhanced green fluo-
rescent protein (eGFP) (see Figure S1A available online; Gessner
et al., 2005), showed heterogeneous surface IgE with approxi-
mately 50% of the mast cells having high cell surface-bound
IgE (Figure 1A). In contrast, peritoneal mast cells exhibited
uniform cell-surface IgE. These differences were not a result of
the protease-dependent skin mast cell isolation protocol as
protease-treated peritoneal mast cells showed no loss of surface
IgE (Figure S1B).
Mast cell-bound IgE has a half-life of up to 2 weeks and can
modulate mast cell expression of FcεRI (Gould and Sutton,
2008; Yamaguchi et al., 1997). Therefore, we examined IgE
uptake in IgE-deficient 4getxRag2/mice following intravenous
(i.v.) infusion of 10 mg of IgE. Despite peak IgE titers more than
50-fold greater than physiologic levels in IgE-replete animals
(data not shown), only a select population of ear skin mast cells
demonstrated IgE uptake at 1 hr and continued to accumulateImmunity 38, 166–175IgE throughout the time course (Fig-
ure 1B). In contrast, peritoneal mast
cells showed uniform uptake of IgE at
1 hr and further accumulation of IgE
throughout the time course, similar to
profiles seen at steady state in wild-type
(WT) animals. The ear skin mast cells
also did not demonstrate surface IgE
staining commensurate with peritoneal
mast cells. Although slightly lower than
on peritoneal mast cells, FcεRI expres-
sion on skin mast cells could not account
for this discrepancy (Figure 1C). Similar
results were obtained with a smaller
1 mg infusion but with markedly lower
IgE uptake in the ear (Figure S1C). To-
gether, these data suggested that skin
blood vessels regulate IgE traffickinginto the tissue and that select mast cell populations had greater
access to vascular contents. The data predicted that IgE uptake
would similarly localize to perivascular mast cells.
Characterization of Reporter IgE Molecules and
Localization of IgE Uptake
To visualize IgE uptake in tissues, we constructed a reporter IgE
molecule consisting of a tandem red fluorescent protein (tdRFP)
fused N-terminal to the Cε2–Cε4 domains of the IgE heavy chain
(Cheng et al., 2010). The resulting homodimeric surrogate IgE
molecule has a similar molecular weight as native IgE (188 kDa
versus 200 kDa for native IgE). After an i.v. infusion, RFP-Fcε
was found on the cell surface of FcεRI+ cells, including splenic
basophils and peritoneal mast cells (Figure 2A). Additionally,
gating of peritoneal exudate cells and total splenocytes on
RFP+ cells revealed that essentially all of these cells were mast
cells or basophils, respectively (Figure 2B). Similar to data with
native IgE, only a subset of skin mast cells captured RFP-Fcε, January 24, 2013 ª2013 Elsevier Inc. 167
Figure 2. Characterization of RFP-Fcε
(A and B) We isolated peritoneal mast cells (left column) and splenic basophils
(right column) from 4get BALB/c mice infusedwith 1 mg of RFP-Fcε i.v. one day
prior. In (A), we gated for c-kit+GFP+ mast cells and CD49b+GFP+ basophils
and examined RFP-Fcε capture (bottom row, black histograms). Gray histo-
grams represent similarly gated cells from noninfused mice. In (B), we took
total live cells from the peritoneum (left column) or spleen (right column) and
analyzed all RFP+ cells. RFP+ cells were then gated on c-kit+GFP+ mast cells
(left contour plot) and CD49b+GFP+ basophils (right contour plot). The percent
of cells lying in the respective gate is noted.
(C) We isolated ckit+GFP+ ear skin mast cells from 4get BALB/c mice one day
following an i.v. 10 mg RFP-Fcε infusion. The black histogram represents the
percent RFP+ cells within the indicated gate. The gray histogram represents
RFP fluorescence from a noninfused animal.
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168 Immunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc.after a 10 mg i.v. infusion (Figure 2C). Together, these data indi-
cated that RFP-Fcε displays similar binding and distribution
characteristics to native IgE.
To visualize the distribution of mast cell IgE uptake, we infused
10 mg RFP-Fcε i.v. into WT or mast cell-deficient KitW-sh/W-sh
(Sash) mice (Wolters et al., 2005). After 24 hr, we counterstained
blood vessels in vivo with i.v. tomato lectin FITC and examined
whole mounts of ear tissue by using confocal microscopy (Fig-
ure 3A). WT mice showed an abundance of RFP+ cells with
most cells lying in a perivascular location. In contrast to WT
mice, mast cell-deficient mice demonstrated no RFP+ cells in
the ear skin, though RFP+ basophils could be demonstrated
within the vasculature (Figure 3A). We next sought to obtain
quantitative data to examine whether RFP+ mast cells tended
to be closer to blood vessels than the total mast cell pool.
When bred to a cre-dependent lineage reporter mouse, such
as Rosa-YFP (Srinivas et al., 2001), MCPT5cre reporter mice
(M5Rosa-YFP) allow specific visualization of >90% of mast cells
within the ear skin (Dudeck et al., 2011; Scholten et al., 2008).
After infusion with RFP-Fcε, RFP-Fcε was found on 50% of
mast cells (Figure 3B), and some RFP-Fcε+ mast cells appeared
to direct cellular projections toward the blood vessel though
these initial studies lacked the resolution to define these projec-
tions (Figure 3C).
Whereas RFP-Fcε+ and RFP-Fcεmast cells were both found
to associate with the vasculature, RFP+ mast cells were on
average 35% closer to the nearest blood vessel compared to
the total mast cell population (Figure 3D). In addition, nearly
half of the RFP+ cells were within 2 mm of the nearest blood
vessel, whereas only one quarter of the total mast cell population
was similarly positioned (Figure 3D). Together, these data indi-
cated that perivascular mast cells preferentially acquire IgE
from the blood, and we hypothesized that mast cells might
directly sample blood to acquire IgE.
Perivascular Mast Cells Have Access to Blood Contents
We first took a flow cytometric approach to demonstrate that
mast cells have direct access to blood contents. Similar to es-
tablished approaches (Pereira et al., 2009; Zachariah andCyster,
2010), we infused 4get mice with a c-kit monoclonal antibody
(2B8) conjugated to a high molecular weight fluorophore, phyco-
erythrin (PE). If allowed to circulate for a short period of time,
PE-antibody conjugates remain intravascular and binding to tar-
get cells requires either direct blood exposure or sampling of
intravascular contents. After a 5 min infusion, we observed that
Figure 3. Perivascular Mast Cells Preferen-
tially Capture RFP-Fcε from Blood In Situ
(A) WT or mast cell-deficient (Sash) mice received
10 mg of RFP-Fcε i.v. and were analyzed for RFP-
Fcε uptake by confocal microscopy 24 hr later.
Images represent 12 and 15 mm z projections from
whole mounts of ear tissue. Yellow arrows highlight
representative RFP+ mast cells, yellow arrowheads
indicate hair follicles, and the open arrowhead in
the right panel indicates a basophil. Tomato lectin
was used to counterstain blood vessels. Images are
representative of results from eight separate mice.
Scale bars represent 50 mm.
(B) A maximum intensity projection derived from
a 24 mm z stack of ear skin from a M5cre x Rosa-
YFP mouse with a z step size of 0.5 mm. The mouse
received 10 mg of RFP-Fcε i.v. 1 day prior and anti-
CD31 to label blood vessels 10min prior to analysis.
Scale bars represent 50 mm. The white arrowhead
highlights a YFP+ mast cell with peripheral RFP-Fcε
in blue. Images are representative of ten individual
z stacks.
(C) The left panel represents a zoomed in view of the
box in 3B. In the right panel, the borders of the blood
vessel wall are denoted bywhite lineswith the green
projection of the mast cell body within the bound-
aries of the vessel wall.
(D) Total YFP+ mast cells or RFP+ mast cells from
M5cre x Rosa-YFP mice that had received 10 mg of
RFP-Fcε i.v. 1 day prior were examined for mean
distance from the nearest blood vessel. The left
panel depicts the average distance of the indicated
mast cell population from the nearest blood vessel,
and the right panel represents the percent of mast
cells within the indicated distance range from the
nearest blood vessel. Four z stacks were analyzed
with a total of 613 YFP+ mast cells and 308 RFP+
mast cells. Graph in left panel depicts mean ± SEM.
*p < 0.0001
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Skin Mast Cells Probe Blood Vessels to Acquire IgEapproximately 15%–20% of mast cells captured 2B8-PE (Fig-
ure 4A). Capture of 2B8-PE was not IgE-dependent because
Fcer1a/ mice showed similar 2B8-PE uptake when compared
to WT animals.
As noted in our prior experiments, peritoneal mast cells dis-
play rapid and uniform acquisition of IgE (Figure 1). To examine
whether peritoneal mast cells similarly display direct access to
the blood, we assessed 2B8-PE binding in these cells. Consis-
tent with a lack of direct access to the blood and in contrast to
ear skin mast cells, peritoneal mast cells showed no binding of
2B8-PE after i.v. exposure (Figure 4B). This was not due to an
inherent inability to bind this antibody because intraperitoneal
(i.p.) injection of 2B8-PE led to rapid binding to peritoneal mast
cells but essentially no binding to skin mast cells (Figure 4B).
We next sought to characterize the positioning and dynamics
of mast cell projections and blood vessels (Figure 3B). To in-
vestigate this, we employed intravital, high-resolution confocal
microscopy in MCPT5-cre x Ai6 mice (M5Ai6), which allowed
for greater detail in visualization of mast cells and cellular projec-Immunity 38, 166–175tions in vivo (Madisen et al., 2010). Similar
to our static imaging, we found mast cells
closely approximated to blood vesselsmarked with labeled anti-CD31 antibody (Figure 5A). We
observed two distinct probing phenomena. First, some mast
cells demonstrated relatively stable projections in the interior of
blood vessels (Figure 5A; Movie S1). As we followed such cells
in time, serial images demonstrated the retraction of projections
(Figure 5B; Movie S2). In Figure 5B, the projection retracted
approximately 5 mm over 30 min. We also noted a second
behavior in which mast cells serially interacted with the vessel
wall and/or the interior of the lumen with portions of the cell
body or a cellular projection (Figure 5C; Movie S3).
Because mast cells would not be expected to penetrate blood
vessels ensheathed in smooth muscle, including arterioles, we
also examined the distribution of mast cells in relation to smooth
muscle actin (SMA)-positive vessels. Ear skin whole-mount
tissue demonstrated a relative paucity of SMA+ blood vessels
at the periphery of the ear where we performed dynamic imaging
(Figure S2A). These data indicate that distal ear skin primarily
contains capillary beds and smaller venules. Consistent with
the representation of SMA+ vessels in the ear skin, mast cells, January 24, 2013 ª2013 Elsevier Inc. 169
Figure 4. Mast Cells Probe Blood to Access
Vascular Contents
(A)Within 5min after i.v. injection of isotype control
(left) or 2B8 (middle and right) antibodies conju-
gated to PE, we examined c-kit+GFP+ ear skin
mast cells for antibody uptake in WT (left and
middle) or Fcer1a/ animals (right) from 4get
BALB/c mice. Data are representative of three
experiments with two to six samples per group.
Numbers represent the percent of PE-positive
cells in each sample. Shaded histograms repre-
sent mice that did not receive labeled antibody.
(B) 4get BALB/c mice received 2B8-PE either i.v.
(top row) or i.p. (bottom row), and 5 min later, we
examined ear skin (left column) or peritoneal (right
column) mast cells for 2B8-PE uptake (black
histograms). Gray histograms depict noninfused
animals. The percent of cells within the indicated
gates are depicted within each plot.
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as 3% of mast cells were positioned within 2 mm of SMA+
vessels compared to 25% found disposed near CD31+ blood
vessels in general (Figure S2B). We next examined whether
mast cells with recent IgE uptake showed a similar pattern of
IgE uptake. After infusion with RFP-Fcε, we stained fixed ear
tissue for SMA. Though our analysis was limited by a drop in
RFP signal following fixation, weobserved that RFP+ cells tended
to be in locations remote from SMA+ vessels (Figure S2C).
We next examined fixed ear tissue to further define the entry
point of the cellular extensions at the blood vessels. After a brief
period of labeling blood vessels in vivo with anti-CD31 mono-
clonal antibody, we harvested ear tissue and analyzed fixed
tissue by using confocal microscopy on ear skin whole mounts.
Optical sectioning of the tissue indicated that extensions from
the mast cell entered the blood vessel at areas with diminished
CD31 staining, suggesting penetration of the vessel lumen (Fig-
ures 5D and 5E). In Figure 5E, the extension makes an abrupt
turn as it traverses the vessel wall and then associates with the
lumen of the vessel wall.
Although our data indicated that mast cell sampling of blood
contents is an efficient means for perivascular mast cells to
capture free IgE, other mechanisms could also contribute.
Loading ofmonomeric IgE ontomast cells is thought tomodulate170 Immunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc.mast cell function, including the possi-
bility of piecemeal degranulation (Kawa-
kami and Galli, 2002), which could lead
to local changes in vasopermeability
and increased IgE diffusion. By using
cell surface CD107a and diminished
side-scatter profile as markers of mast
cell activation and degranulation, we
examined whether IgE loading on mast
cells resulted in changes in either of
these parameters (Gekara and Weiss,
2008). To ensure uniform loading of
mast cells during the assay, we used
peritoneal mast cells as our source of
mast cells. Following an i.v. infusion ofIgE, peritoneal mast cells demonstrated baseline expression
of CD107a and native SSC profiles, which contrasted with
control antigen-IgE-activated mast cells (Figure 6A). To directly
address the importance of secreted mast cell products, such
as histamine, on IgE uptake in skin, we used a pharmacologic
approach to block H1 and H2 histamine receptors and mast
cell degranulation. IgE loading in ear skin mast cells was not
affected by these inhibitors (Figure 6B).
We next wanted to determine whether mast cell projec-
tions directly interact with intravascular IgE. Because fluores-
cence of RFP-Fcε was too insensitive for this application, we
developed a technique by using streptavidin-coated beads
coupled to biotinylated IgE and a fluorescent dye. After an
infusion of 109 beads, beads were found in systemic circula-
tion but were cleared within 15 min (data not shown). As a
control, we used dye-coated beads. After infusion of control
beads into mast cell reporter mice, we found a few beads
near perivascular mast cells but no interaction with the bead
(Figure 7A; Movie S4). In contrast, mast cells showed interac-
tions with IgE-coated beads in the form of projections extend-
ing toward an intravascular bead and engulfing it (Figure 7B;
Movies S5 and S6).
To further establish the capacity of mast cells to capture intra-
vascular IgE, we determined the number of IgE-coated beads in
Figure 5. Mast Cells Are Tightly Associated with Blood Vessels and Can Dynamically Sample the Intravascular Lumen
(A) A 25 mmmaximum intensity projection of twomast cells (green and labeled 1 or 2). Both mast cells are adjacent to blood vessels (blue). The scale bar is 10 mm.
z stack is representative of imaging performed on three individual mice.
(B) Single z slices of Cell 1 in (A) starting at time 0 on the left. The boundaries of the blood vessel are then depicted only aswhite solid lines for the remainder of the z
slices. Each frame is separated by6min and shows the withdrawal of the projection observed at time 0 and highlighted by the white arrowhead in the first panel.
(C) Single z slices of Cell 2 in (A) starting at time 0 on the left. The boundaries of the blood vessel are then depicted only aswhite solid lines for the remainder of the z
slices. Each frame is separated by 5 min and shows serial interactions between the mast cell and blood vessel with portions of the mast cell body in the vessel
lumen at (t = 38 and 43) or a projection directed into the vessel at t = 58). A white arrowhead at t = 58 denotes the mast cell projection.
(D and E) Single optical sections from M5creAi6 mice with CD31-labeled blood vessel in blue and mast cells in green. The left panel depicts the vessel alone,
whereas the right panel is merged with the mast cells. The areas of decreased CD31 signal are depicted by the white arrowheads. Scale bar represents 10 mm in
(D) and 3 mm in (E).
See also Figure S2 and Movies S1, S2, and S3.
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we recovered an average of 1,337 beads per mg of ear tissue
(Figure 7C). In contrast, mast cell deficient (MCPT5cre x Rosa-
DTA) mice exhibited a nearly 70% drop in bead recovery.
Together, these data indicate that mast cells interact directly
with intravascular contents in a dynamic fashion and selectively
remove IgE from blood.
DISCUSSION
The acquisition of IgE by mast cells is central to mast cell func-
tion, and the importance of this interaction has been under-
scored by two recent studies (Dudeck et al., 2011; Feyerabend
et al., 2011). Given the critical role of IgE in mast cell biology,
our study sought to examine how tissue mast cells acquire IgE.
The studies presented here indicate that IgE acquisition by
mast cells is regulated at the level of the vasculature with peri-
vascular mast cells demonstrating selective uptake of IgE from
the blood. Further understanding into the regulation of mast
cell IgE uptake may also provide new therapeutic approaches,
as well.
Immune surveillance of intravascular components has been
previously described in professional antigen presenting cells(APC), including intra-aortic dendritic cells and Kupffer cells,
which also reside within the vasculature (Choi et al., 2009; Lee
et al., 2010). Our data illustrate that extravascular cells are
also capable of probing blood, akin to sampling of intralumi-
nal contents in the gastrointestinal and respiratory tracts by
CD103+ dendritic cells (Chieppa et al., 2006; Lambrecht and
Hammad, 2009; Rescigno et al., 2001). Mast cells are not gener-
ally considered to be antigen-presenting cells, though mast cells
may express MHC class II under specific conditions (Kambaya-
shi et al., 2009). Instead, intravascular sampling appears to be
a means for mast cells to capture unbound IgE, which in turn
could promote mast cell function and survival (Kawakami and
Galli, 2002; Kraft and Kinet, 2007).
Tissue mast cells have long been known to project dendrites,
although the function of these projections has not been clear.
Beyond sampling blood, mast cells may also extend projections
for intercellular communication through a network of cytonemes.
The significance of these projections has not been examined
in vivo (Fifadara et al., 2010).
We speculate that in addition to capturing IgE, mast cells
employ this sampling mechanism as part of a sentinel function
in host defense. Localization to barrier surfaces, the capacity
to induce immediate inflammatory responses, and the ability toImmunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc. 171
Figure 6. IgE Loading Does Not Cause
Degranulation and Is Unaffected by Phar-
macologic Inhibition of Mast Cell Function
(A) 4get BALB/c mice received either PBS (solid
black line) or monoclonal anti-TNP IgE anti-
body (dashed line) i.v. Four hours later, surface
LAMP-1 (CD107a) and granularity (side scatter)
were examined on peritoneal mast cells. An
additional control group for mast cell activation
is represented by the blue line. This group of
mice had been loaded with anti-TNP IgE 1 day
prior and challenged with 1 mg of TNP-ovalbumin
at the start of the experiment. These activated
mast cells demonstrate increased LAMP-1
staining after activation as well as a drop
in side-scatter (SSC). By contrast, IgE-loaded
mast cells show equivalent LAMP-1 and SSC
profiles compared to controls. The gray histo-
gram in the left panel represents isotype control
staining.
(B) 4getxRag2/ mice were pretreated with PBS
(left panel) or a combination of pyrilamine, raniti-
dine, and cromolyn sodium (right panel). Mice
were then loaded with 10 mg of monoclonal IgE
antibody and ear mast cells assessed for IgE
uptake 24 hr later.
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responders to pathogen invasion. Specific IgE further enhances
these functions when antigen is present. Although local pro-
duction of IgE has been described in the airway mucosa (Gould
and Sutton, 2008), delivery to the skin and mucosal sites remote
from IgE production requires systemic distribution. The sur-
veillance mechanism we describe limits distribution of IgE to
subsets of mast cells in close approximation to the vasculature.
Thus, the cells most likely to influence vascular permeability after
activation also have the greatest access to free IgE. It remains
unclear whether this anatomic positioning also defines subsets
of mast cells that have functional differences beyond the effects
of IgE.
Our studies focus on the steady-state means by which mast
cells acquire IgE. Local changes in vascular permeability, which
could be seen with immediate hypersensitivity reactions, infec-
tion, or dermatitis, may further modulate IgE loading. In addition,
the disparate mechanisms by which skin and peritoneal mast
cells acquire IgE suggest that IgE uptake may be organ-specific.
Several factors, including mast cell positioning, local vascular
permeability, and the predominant mast cell populations (con-
nective tissue versus mucosal) contained within each organ
may all play a role in IgE acquisition.
Our data uncover a regulated means by which mast cells
acquire IgE and fill an important gap in our understanding of172 Immunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc.the steps required in the elicitation
of hypersensitivity by mast cells. The
molecular mechanism by which mast
cells survey blood remains undefined.
We hypothesize that a gradient between
blood and tissue of a particular factor
or family of molecules may drive mast
cell sampling behavior. Further under-standing of the mechanism by which mast cells survey the blood
compartment may provide a means to modulate human allergic
disease in the future.
EXPERIMENTAL PROCEDURES
Mice
4get BALB/c and IgE-deficient 4getxRag2/ mice have been described
(Cheng et al., 2010; Mohrs et al., 2001). Mast cell-deficient KitW-sh/W-sh
(Sash) mice on a C57BL/6 background were provided by G. Caughey
(UCSF). MCPT5 Cre mice were bred to either of the following reporter mice:
Rosa-YFP, Ai6, or Rosa-DTA (Madisen et al., 2010; Srinivas et al., 2001; Voeh-
ringer et al., 2008). Rosa-YFP and Ai6 mice were obtained from Jackson
Laboratories (Bar Harbor, ME). Mice were housed in Specific Pathogen Free
facilities. Experimental mice were 8–10 weeks old. Animal use was governed
by and in accordance with approved protocols overseen by the Laboratory
Animal Resource Center (LARC) and Institutional Animal Care and Use
Committee (IACUC) at UCSF.
Skin Tissue and Peritoneal Mast Cell Isolation
Ear tissue from euthanized mice was split into dorsal and ventral halves and
then minced. Tissue was resuspended in PBS plus 2 U/ml of Liberase CI
(Roche) and incubated at 37C for 45 min in an orbital shaker similar to pub-
lished protocols (Grimbaldeston et al., 2007). Collagenase activity was
quenched with PBS supplemented with 2% fetal calf serum (FCS), and the
cells were analyzed by flow cytometry. Peritoneal mast cells were analyzed
from lavage fluid collected after euthanasia. The gating scheme was similar
to a previously published study (Gessner et al., 2005).
Figure 7. Mast Cells Capture Intravascular
IgE-Coated Beads
(A) A single z slice depicting a mast cell (green)
directing projections into a blood vessel (blue)
but not interacting with fluorescent beads (red).
Ten minutes prior to imaging, the M5cre x Ai6 mast
cell reporter mouse received 109 rhodamine-
coated beads i.v. Scale bar represents 10 mm. The
left panel shows the native image, whereas the
right panel highlights the boundaries of the vessel
with improved visualization of the projections.
Images are representative of five individual imaging
volumes. One of the IgE beads is also denoted by
a red arrowhead in the right panel.
(B) A single z slice illustrating a mast cell (green)
directing a projection into a blood vessel (blue) and
interacting with an IgE bead (red) distally. The IgE
bead is also denoted by the red arrowhead. Ten
minutes prior to imaging, the M5cre x Ai6 mast cell
reporter mouse received 109 IgE and rhodamine-
coated beads i.v. The left panel shows the native
image, whereas the middle panel highlights the
boundaries of the blood vessel. The right panel is
an orthogonal view of the z stack. The mast cell
(green), bead (red), and blood vessel (gray) have
been rendered into surfaces. Scale bar represents
10 mm. Images are representative of five individual
imaging volumes.
(C) Approximately 109 IgE coated beads were
infused i.v. into WT or mast cell-deficient
(M5creDTA) mice and subsequently isolated from
ear tissue after weighing. The number of beads is
represented as the number of beads per mg of ear
tissue. *p < 0.01.
See also Movies S4, S5, and S6.
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RFP-Fcε was constructed and produced in the same manner as previous
molecules (Cheng et al., 2010). A primer pair (50- TTTAGATCTGTGAGC
AAGGGCGAGG-30 and 50-TGGATCCCTTGTACAGCTCGTCCATGC-30) that
spanned amino acids 2–476 was used to amplify the tdRFP cDNA (Shaner
et al., 2004).
Antibodies and Flow Cytometry
For mast cell staining, we used the following antibody clones: c-kit (ACK2,
eBioscience, San Diego, CA), FcεRI (Mar-1, eBioscience). For basophil stain-
ing, we used CD49b (DX5, eBioscience). For in vivo infusion, the following anti-
bodies and clones were used: mouse IgE C38-2 (BD PharMingen, San Diego,
CA) anti-CD31 APC (390, eBioscience), tomato lectin FITC (Vector Labs, Bur-
lingame, CA), anti-c-kit PE (2B8, eBioscience). For flow cytometry, we used an
LSRII (Becton Dickinson, San Jose, CA) for data acquisition and analysis.
We performed postacquisition analysis by using FlowJo software (Treestar,
Ashland, OR).
Mast Cell Blood Sampling
One microgram of PE-conjugated 2B8 or isotype control rat IgG2b antibody
was infused i.v. into the tail veins of mice. Within 5 min, mice were euthanized
with immediate processing of tissue for flow cytometry. Statistical analysis
was performed by using an unpaired t test.
Confocal Microscopy
For confocal microscopy, ear tissue from euthanizedmice was split into dorsal
and ventral halves (except for experiments involving bead infusions for whichthe ears remained intact). The tissue was then bathed in Vectashield (Vector
Labs) and analyzed with a Nikon C1si laser scanning confocal microscope.
Images were analyzed and rendered by using Imaris software (Bitplane, Zur-
ich, Switzerland). To analyze the distance from mast cells to blood vessels,
we used Imaris software to mark the boundaries of the blood vessels and to
generate ‘‘spots’’ to represent index populations. The software then calculated
the distance from the center of each of these spots to the edge of the nearest
blood vessel. A Student’s t test was performed for significance on the resulting
data sets. For fixed tissues, micewere fixedwith 4%paraformaldehyde in PBS
for 2 hr on ice. Samples were then washed and analyzed as above.
Intravital Microscopy
Mice received intraperitoneal injections of ketamine and xylazine for anes-
thesia. Mice were then placed in a lateral decubitus position on the imaging
stage of a Nikon C1si microscope. The ventral half of the ear was then
dissected away with preservation of blood flow to the dorsal half verified
under light microscopy. The mouse was then secured on the stage with the
microscope objective directed toward the dermal surface. Images were
compiled, analyzed, and rendered by using Imaris software (Bitplane, Zurich,
Switzerland).
IgE Beads
Monoclonal, anti-trinitrophenol IgE (C38-2) was biotinylated with EZ-Link Sulfo
NHS (Thermo Scientific, Rockford, IL). After purification (Zeba Spin Desalting
columns, Thermo Scientific), 40 mg of IgE (4B12, Vector Labs) was then com-
bined with 109 Dynal MyOne T1 streptavidin beads for 15 min (Invitrogen,
Carlsbad, CA). To quench unoccupied streptavidin moieties and label theImmunity 38, 166–175, January 24, 2013 ª2013 Elsevier Inc. 173
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was added to the mixture for 15 min (Invitrogen). The beads were then washed
and resuspended in PBS prior to i.v. infusion. Ten minutes after infusion, ears
were dissected from euthanized mice and analyzed intact by using confocal
microscopy. For the bead recovery assay, ears were harvested 20 min after
infusion, weighed, and placed directly into digest buffer (0.25% SDS, 0.1 M
NaCl, 50 mM Tris pH 8, 7.5 mM EDTA) with an additional 0.5 mg/ml Proteinase
K for 3 hr at 56 degrees and constant agitation. Magnetic beads were then iso-
lated by using a Dynal magnet (Invitrogen, Carlsbad, CA) after multiple washes
with PBS and resuspended in 100 ml of water. The beads were then counted
manually with a hemacytometer.
LAMP-1 Staining
Four hours after i.v. IgE infusion or i.p. challengewith 1mg of TNP-ovalbumin in
sensitized animals, peritoneal lavage fluid was isolated and ckit+GFP+ mast
cells were stained with anti-CD107a (1D4B, eBioscience).
Histamine Blockade and Cromolyn Sodium Administration
Mice received inhibitors of mast cell degranulation (cromolyn) and histamine
blockade per published protocols (Dawicki et al., 2010).
SUPPLEMENTAL INFORMATION
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